Xiaofei Cong is an experienced scientist specializing in immunology and biomarker research. With a Doctor of Philosophy in Growth Biology from Virginia Tech, Xiaofei's career includes roles such as Postdoctoral Scholar at Eastern Virginia Medical School, where research focused on TRIM72's role in lung injury and innate immunity, and Research Scientist at Bayer Pharmaceuticals, leading pre-clinical drug R&D projects. Xiaofei also served as Scientist II at Labcorp Drug Development, mastering Good Clinical Practices while providing troubleshooting support for patient sample testing. As Senior Research Scientist at Labcorp, leadership was demonstrated in biomarker immunoassay validation for global projects. Currently, Xiaofei serves as Senior Director at Eli Lilly and Company, spearheading diagnostic collaborations for clinical projects.
This person is not in the org chart
This person is not in any teams
This person is not in any offices